BEHANDLUNG VON AUGENERKRANKUNGEN
Patent europeic · EP3501536 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP3501536
- Numer da la dumonda
- EP18202143
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 15-10-2012
- Publitgà
- 26-06-2019
- Concedì
- 24-12-2025
- La protecziun finescha il pli tard
- 14-10-2032
- Proxima taxa annuala scadenta
- 31-10-2026
- Classas IPC
- A61K 39/395 (2006.01)
- Prioritad
- US 201161546708 P 13.10.2011
- Derivà da
- EP12840725
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 14-01-2026
Owner
- Owner
- EyePoint Pharmaceuticals, Inc., 480 Pleasant Street, Suite A-210, Watertown, MA 02472, USA → EyePoint, Inc., 480 Pleasant Street, Suite A-210, Watertown, MA 02472, USA
Published in Swissreg on 14.01.2026
- 24-12-2025
Concedì
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 24.12.2025
Partidas
Inventur
PETERS, Kevin
Cincinnati, OH 45242, US
SHALWITZ, Robert
Bexely, OH 43209, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.